- Covid vaccine gives Pfizer sales and profits a big boost CNN
- Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill CNBC
- Pfizer stock falls after profit beats but revenue misses, even as COVID-19 vaccine sales of $12.5 billion top forecasts MarketWatch
- Pfizer Forecasts $54 Billion in 2022 Sales From Its Covid-19 Vaccine, Treatment The Wall Street Journal
- Pfizer’s 2022 outlook falls short of Wall Street’s lofty expectations Financial Times
- View Full Coverage on Google News
Top stories – Google News
